Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹18 Cr₹60 Cr₹58 Cr₹46 Cr₹58 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹18 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹18 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹18 Cr
-69.12
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,005.3 Cr -3.9% -12.2% 153% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,048.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 5.9% -3.7% -6.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-3.9%

-12.2%

153%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses